197. Deputy Joan Collins asked the Minister for Health if the HSE high level officials group has made a recommendation on the reimbursement of Orkambi and the extension of Kalydeco for the two to five age group and the R117h group of persons with cystic fibrosis eligible for these vital drugs; and if he will make a statement on the matter. [8974/17]

Summary

197. Deputy Joan Collins asked the Minister for Health if the HSE high level officials group has made a recommendation on the reimbursement of Orkambi and the extension of Kalydeco for the two to five age group and the R117h group of persons with cystic fibrosis eligible for these vital drugs; and if he will make a statement on the matter. [8974/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 22 February 2017

   Medicinal Products Reimbursement

   197. Deputy Joan Collins asked the Minister for Health if the HSE high level officials group has made a recommendation on the reimbursement of Orkambi and the extension of Kalydeco for the two to five age group and the R117h group of persons with cystic fibrosis eligible for these vital drugs; and if he will make a statement on the matter. [8974/17]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Reimbursement

  xml · EN · 22 February 2017

  ViewDownloadOpen at official source

Sponsors

• Joan Collins · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.